National Medical Products Administration | Accelerating the Drafting of the Medical Device Management Law

From January 18 to 19, the 2024 National Medical Device Supervision and Management Work Conference was held in Beijing.

The Conference summarized the work in 2023, analyzed the current situation, and deployed five key tasks for medical device supervision in 2024, such as “focusing on accelerating the drafting of the medical device Management Law and accelerating the improvement of the regulatory basic support system” :

The Conference pointed out that in 2023, the drug regulatory authorities continued to deepen the reform of the medical device review and approval system, innovative products continued to emerge, high-quality development to accelerate the service of the major national strategies as a strong; continue to strengthen the review and approval of epidemic prevention and control of products and quality supervision, and strong protection of the normal epidemic prevention and control; strengthen the second class of product registration, the first class of products for the record and the management of clinical trials; the comprehensive application of Comprehensive use of a variety of means, comprehensively strengthen the quality and safety supervision of the whole life cycle; focus on the key to strengthen the remediation, consolidate and enhance the action to achieve significant results; improve the regulatory system, promote regulatory scientific research, strengthen the standard classification and other management, the regulatory foundation continues to be consolidated; to promote the construction of information technology, strengthen the construction of the regulatory system, the regulatory ability to move to a new level; vigorously strengthen international exchanges and cooperation, and actively participate in the international standardisation work, the international influence and appeal continues to expand. The international influence and appeal are expanding.

Source：CMDRA